Sort
27,075 grants matching “cholesterol”
Significance of CYP46A1 and other P450s in retinal function
$384,650Irina A Pikuleva · Case Western Reserve University · R01 · FY2014 · EY
Regulation of AT1R-signaling and pathology in vessels through microRNA
$384,650Sadashiva S. Karnik · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Role of cholesteryl ester transfer protein in cellular lipid homeostasis
$384,650Richard E Morton · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL
Lipid Rafts in Adenoviral Ocular Pathogenesis
$384,650Jaya Rajaiya · Massachusetts Eye And Ear Infirmary · R01 · FY2014 · EY
Nuclear Receptor Functional Profiling in Metabolism and Disease
$384,630Ronald M. Evans · Baylor College Of Medicine · U19 · FY2011 · DK
Amoeboid Membrane Dynamics in Prostate Cancer
$384,579Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2014 · CA
EXTRACT OF GINKGO BILOBA (EGB 761) AND VASCULAR FUNCTION
$384,520Stanford University · R01 · FY2000 · AT
Genomic analysis of C. elegans fat regulatory pathways
$384,498Gary B. Ruvkun · Massachusetts General Hospital · R01 · FY2006 · DK
ABCA1 cholesterol efflux & protein-protein interactions
$384,498Michael Leo Fitzgerald · Massachusetts General Hospital · R01 · FY2006 · HL
Studies of Isoprenoid Biosynthesis
$384,493University Of Utah · R01 · FY2004 · GM
Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis
$384,492John Daniel Clarke · Washington State University · R01 · FY2024 · ES
The Mechanism of Shear-Induced Release and Activation of TGF-beta1
$384,477Jasimuddin Ahamed · Oklahoma Medical Research Foundation · R01 · FY2015 · HL
PI4KIIα in Late Stage Autophagy
$384,453Helen L Yin · Ut Southwestern Medical Center · R01 · FY2017 · GM
Oxysterols, Estrogen Receptor Antagonism, and Vascular Disease
$384,442Philip W Shaul · Ut Southwestern Medical Center · R01 · FY2014 · HL
Electrostatic Interaction of ENaC, MARCKS-like protein, and PIP2
$384,414Douglas C Eaton · Emory University · R01 · FY2025 · DK
BMP2 Gene Regulation in Calcific Aortic Valve Disease
$384,400Douglas P Mortlock · Vanderbilt University · R01 · FY2012 · HL
Acyl-CoAs and Lesion Initiation in Diabetes
$384,387Karin E. Bornfeldt · University Of Washington · R01 · FY2007 · HL
Cholesterol Regulation of Endothelial K+ Channels
$384,341Irena Levitan · University Of Illinois At Chicago · R01 · FY2012 · HL
Chemical Biology of the Gut Microbiome: Target Discovery and Disease Therapeutics
$384,239M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2019 · GM
Chemical Biology of the Gut Microbiome: Target Discovery and Disease Therapeutics
$384,239M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2018 · GM
Using agent-based modeling to compare strategies that can reduce rural-urban disparities in cardiovascular disease
$384,237Donglan Zhang · University Of Georgia · R01 · FY2021 · MD
LIPOPROTEIN-RELATED CVD RISK FACTORS: QTL IDENTIFICATION
$384,204Michael C. Mahaney · Texas Biomedical Research Institute · P01 · FY2010 · HL
LIPOPROTEIN-RELATED CVD RISK FACTORS: QTL IDENTIFICATION
$384,204Michael C. Mahaney · Texas Biomedical Research Institute · P01 · FY2011 · HL
Sleep and Cardiovascular Health
$384,198Phyllis C Zee · Northwestern University At Chicago · R01 · FY2012 · HL
LIPOPROTEIN-RELATED CVD RISK FACTORS: QTL IDENTIFICATION
$384,182Michael C. Mahaney · Texas Biomedical Research Institute · P01 · FY2012 · HL